ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,884.10
      -0.04%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Arbutus Biopharma Corporation (ABUS)

      7. Arbutus Biopharma Corporation (ABUS) Financials

      Arbutus Biopharma Corporation

      Arbutus Biopharma Corporation (ABUS)

      NASDAQ
      3.90
      -0.02
      (-0.51%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      3.90
      0.00
      (0.00%)
      After Hours: 4:30PM
      Delayed by 15 minutes

      Arbutus Biopharma Corporation Financial Summary

      The current ABUS market cap is 736M. The company's latest EPS is USD -0.3860 and P/E is -10.05.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 6.69M5.01M4.45M2.15M1.53M
      Operating Income -17.41M-18.66M-21.56M-20.59M-19.36M
      Net Income -16.34M-17.09M-20.1M-19.31M-17.88M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 6.01M6.91M10.99M39.02M18.14M
      Operating Income -144.07M-57.33M-73.52M-65.46M-78.1M
      Net Income -153.72M-75.87M-88.39M-69.46M-72.85M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 191.22M176.82M158.64M144.4M150.29M
      Total Liabilities 47.31M42.13M39.3M38.38M35.65M
      Total Equity 143.92M134.69M119.34M106.02M114.64M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 105.54M137.08M204.49M195.42M144.4M
      Total Liabilities 32.79M35.11M35.05M58.57M38.38M
      Total Equity 72.74M101.97M169.44M136.85M106.02M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -27.3M-46.86M-68.64M-85.94M-19.3M
      Investing 16.68M18.12M28.55M50.77M11.69M
      Financing 20.42M25.16M26.84M30.65M24.43M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -71.01M-51.44M-67.53M-35.36M-85.94M
      Investing 28.34M-14.91M-12.68M-74.94M50.77M
      Financing 37.46M86.75M137.24M31.81M30.65M

      Stats and Ratios

      Market Cap 736M
      Price to Earnings Ratio -10.05
      Price to Sales Ratio 40.37
      Price to Cash Ratio 27.85
      Price to Book Ratio 6.91
      Dividend Yield -

      Share Statistics

      Shares Outstanding 188.72M
      Average Volume (1 week) 755.95k
      Average Volume (1 Month) 938.21k
      52 Week Change 83.10%
      52 Week High 3.98
      52 Week Low 1.69
      Spread (Intraday) 0.1 (2.53%)

      Company Info

      Company Name Arbutus Biopharma Corporation
      Address 100
      burnaby, british columbia V5J 5J8
      Website https://www.tekmirapharm.com
      Industry pharmaceutical preparations (2834)